S Lashkari B, Anumba D. Estradiol alters the immune-responsiveness of cervical epithelial cells stimulated with ligands of Toll-like receptors 2 and 4. PLoS ONE. 2017;12:e0173646 pubmed publisher

Ulbrich F, Kaufmann K, Roesslein M, Wellner F, Auwärter V, Kempf J, et al. Argon Mediates Anti-Apoptotic Signaling and Neuroprotection via Inhibition of Toll-Like Receptor 2 and 4. PLoS ONE. 2015;10:e0143887 pubmed publisher

Hasheminia S, Zarkesh Esfahani S, Tolouei S, Shaygannejad V, Shirzad H, Hashemzadeh Chaleshtory M. Toll like receptor 2 and 4 expression in peripheral blood mononuclear cells of multiple sclerosis patients. Iran J Immunol. 2014;11:74-83 pubmed publisher

Tolouei S, Hejazi S, Ghaedi K, Khamesipour A, Hasheminia S. TLR2 and TLR4 in cutaneous leishmaniasis caused by Leishmania major. Scand J Immunol. 2013;78:478-84 pubmed publisher

Li J, Fang L, Killer H, Flammer J, Meyer P, Neutzner A. Meningothelial cells as part of the central nervous system host defence. Biol Cell. 2013;105:304-15 pubmed publisher

Ambarus C, Santegoets K, van Bon L, Wenink M, Tak P, Radstake T, et al. Soluble immune complexes shift the TLR-induced cytokine production of distinct polarized human macrophage subsets towards IL-10. PLoS ONE. 2012;7:e35994 pubmed publisher

Zhang M, Liu F, Jia H, Zhang Q, Yin L, Liu W, et al. Inhibition of microRNA let-7i depresses maturation and functional state of dendritic cells in response to lipopolysaccharide stimulation via targeting suppressor of cytokine signaling 1. J Immunol. 2011;187:1674-83 pubmed publisher

Bergin D, Greene C, Sterchi E, Kenna C, Geraghty P, Belaaouaj A, et al. Activation of the epidermal growth factor receptor (EGFR) by a novel metalloprotease pathway. J Biol Chem. 2008;283:31736-44 pubmed publisher